№ lp_1_2_01678
File format: docx
Character count: 25448
File size: 92 KB
This document is an invitation for bids for the supply and installation of an Automated Synthesis unit for the Cyclotron Facility at Necsa.
Year:
2021
Region / city:
South Africa
Subject:
Nuclear energy, radiopharmaceuticals, medical technology
Document type:
Invitation to bid
Organization:
South African Nuclear Energy Corporation (Necsa)
Author:
South African Nuclear Energy Corporation (Necsa)
Target audience:
Bidders, suppliers, contractors
Period of validity:
90 Days (Commencing the bid Closing Date)
Approval date:
Not specified
Date of amendments:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
South Africa
Topic:
Nuclear Energy, Bidding Process, Radiopharmaceutical Equipment
Document Type:
Invitation to Bid
Organization / Institution:
South African Nuclear Energy Corporation (Necsa)
Author:
Not specified
Target Audience:
Bidders for the specified project
Validity Period:
90 Days
Approval Date:
Not specified
Amendment Date:
Not specified
Clarification Session Date:
17 January 2022
Closing Date:
08 February 2022
Closing Time:
11:00 am
Contact Person:
Mr. Buyani Nsibande
Contact Email:
[email protected]
Contact Phone:
+27 (0) 12 305 6072
Year:
2004
Region / City:
General Hospital
Topic:
Radiation Safety
Document Type:
Instruction Sheet
Organization / Institution:
General Hospital
Author:
Dr. John Smith
Target Audience:
Patients receiving radiopharmaceutical therapy
Action Period:
1 day - 26 days post-therapy
Approval Date:
January 1, 2004
Amendment Date:
N/A
Version:
Final Text
Date:
June 7, 2014
Note:
Developed pursuant to DICOM Work Item 2010-04-B
Annex A:
Registry of DICOM unique identifiers (UID)
Annex B:
DCMR Context Groups
Annex C:
Acquisition and Protocol Context Templates
Annex D:
DICOM Controlled Terminology Definitions
Annex J:
SNOMED DICOM Microglossary Retired Codes
Version:
Public Comment Letter Ballot
Send comments to:
[email protected]
Note:
November 4, 2013
Year:
2013
Region / City:
USA
Topic:
Radiopharmaceutical Radiation Dose Reporting
Document Type:
Supplement
Organization / Institution:
DICOM Standards Committee
Author:
DICOM Standards Committee
Target Audience:
Medical Imaging Professionals
Validity Period:
Not specified
Approval Date:
November 4, 2013
Amendment Date:
Not specified
Agency:
Department of Veterans Affairs
Contracting Office:
Network Contracting Office 9
Solicitation Number:
VA249-15-N-0558
Response Date:
June 26, 2015, 11:00 AM Central Time
Archive Days After Response Date:
90
NAICS Code:
325412
Classification Code:
65
Place of Performance:
Nashville, TN 37212
Contracting Office Address:
1639 Medical Center Parkway, Suite 400, Murfreesboro, TN 37129
Delivery Location:
Nuclear Medicine, Room D-40 and Room A-25, VA Tennessee Valley Healthcare System, 1310 24th Avenue South, Nashville, TN 37212
Point of Contact:
Stacey Lamb
Email:
[email protected]
Telephone (fax):
615-849-3714
Set-Aside Status:
To Be Determined Based on Market Research
Type of Notice:
Sources Sought Notice
Project Scope:
Daily provision and delivery of unit dose PET radiopharmaceuticals (FDG, N-13, Amyvid) Monday through Friday, including emergency and holiday services
Regulatory References:
FAR Part 6, FAR Part 10, FAR Part 19, FAR Clause 52.232-33
Registration Requirement:
System for Award Management (SAM)
Year:
2025
Region / City:
Not specified
Theme:
Pharmaceutical product information
Document type:
Product summary
Organization / Institution:
Not specified
Author:
Not specified
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
FedBizOpps Sources Sought Notice for Radiopharmaceutical Supplies – Response Date September 08, 2014
Year:
2014
Response Date:
September 08, 2014, 10:00 AM EST
Solicitation Number:
VA246-14-I-0784
NAICS Code:
325412 (Pharmaceutical Manufacturing)
Agency:
Department of Veterans Affairs
Contracting Office:
Network Contracting Office 6
Place of Performance:
Charles George VAMC, Asheville, North Carolina, USA
Point of Contact:
Dwayne Tillery
Email:
[email protected]
Type of Notice:
Sources Sought Notice
Subject:
Radiopharmaceutical Supplies
Set-Aside:
N325412
Archive Days After Response Date:
60
Description:
Request for information to identify potential sources capable of providing specified radiopharmaceutical products and related items
Submission Requirements:
DUNS number, business size, socio-economic category, GSA or Federal Supply Schedule contract information (if available)
Recovery Act Funds:
Not indicated
Year:
2026
Institution:
University of Latvia, Institute of Chemical Physics
Location:
Riga, Latvia
Authors:
Assoc. Prof. Elīna Pajuste, Mg. chem. Patrīcija Kalniņa, Mg. chem. Edgars Mamis
Type of document:
Research project description
Funding:
Latvian Council of Science, University of Latvia Foundation
Target radionuclides:
149Tb, 152Tb, 155Tb, Sc isotopes
Methods:
Mass separation, electrochemical and chemical purification, ion exchange resins, SEM, EDX, BET, FT-IR, pycnometry
Materials:
TaC, VC, VB, TiC-nanoscale, composite targets
Applications:
Theranostic radiopharmaceutical development, pre-clinical studies
Research facilities:
CERN-MEDICIS, University of Latvia radiochemistry lab
Year:
2012
Region / city:
Pakistan
Topic:
Medical Device Regulation
Document Type:
Application Form
Organization:
Drug Regulatory Authority of Pakistan
Author:
Drug Regulatory Authority of Pakistan
Target Audience:
Manufacturers of medical devices
Validity Period:
Not specified
Approval Date:
Not specified
Date of Last Change:
Not specified
Year:
2021
Region / city:
Zoekfontein
Topic:
Hydropower system design and installation
Document type:
Technical specification
Organization / institution:
Rand Water
Author:
Rand Water Engineering Department
Target audience:
Contractors, engineers, and project managers
Period of validity:
Not specified
Approval date:
Not specified
Date of amendments:
Not specified
Context:
This document outlines the detailed technical and functional requirements for designing, manufacturing, installing, and maintaining a hydropower plant at Zoekfontein Flow Control Works.
Year:
2021
Region / City:
South Africa
Topic:
Nuclear Energy, Bidding Process, Radiopharmaceutical Equipment
Document Type:
Invitation to Bid
Organization / Institution:
South African Nuclear Energy Corporation (Necsa)
Author:
Not specified
Target Audience:
Bidders for the specified project
Validity Period:
90 Days
Approval Date:
Not specified
Amendment Date:
Not specified
Clarification Session Date:
17 January 2022
Closing Date:
08 February 2022
Closing Time:
11:00 am
Contact Person:
Mr. Buyani Nsibande
Contact Email:
[email protected]
Contact Phone:
+27 (0) 12 305 6072
Year:
2021
Jurisdiction:
Czech Republic
Governing law:
Act No. 89/2012 Coll., Civil Code
Type of document:
Purchase contract
Buyer:
Nuclear Physics Institute of the Czech Academy of Sciences, public research institution
Seller:
Unspecified supplier selected through public procurement
Project:
European Spallation Source (ESS) – BEER instrument
Subject matter:
Manufacture and delivery of a safety shutter system
Funding source:
ESS project funds
Procurement procedure:
Below-the-limit public contract, open procedure
Related agreements:
In-Kind Contribution Agreement including Schedule NSS 6.6 #4
Annexes:
Technical specifications, project schedule, incentive and risk management instruments
Purpose:
In-kind contribution by the Czech Republic to ESS infrastructure
Legal status of buyer:
Non-entrepreneur in relation to the contract
Contractual priorities:
Buyer-favourable specifications prevail
Year:
2022
Country:
South Africa
Region / City:
North West Province, Pelindaba, Madibeng Municipality
Organization:
South African Nuclear Energy Corporation SOC Ltd
Bid number:
FBD-SCM-2022-TEN-0001
Document type:
Invitation to bid
Subject matter:
Procurement of a jaw crusher for a smelter project
Closing date:
13 May 2022
Closing time:
11:00
Compulsory site meeting date:
21 April 2022
Bid validity period:
90 working days
Delivery address:
Necsa Gate 3, Pelindaba, Brits Magisterial District
Applicable standards and policies:
ISO 14001, OHSAS 18001, ISO 9001, ISO 17025, RD 0034
Evaluation framework:
80/20 and 90/10 preference point systems
Contracting authority:
South African Nuclear Energy Corporation SOC Ltd
Contact person:
Buyani Nsibande
Bid number:
FIN-SCM-TEN-0053
Bid description:
Manufacture, supply, delivery, installation and commissioning of one jaw crusher for a smelter project
Issuing organization:
South African Nuclear Energy Corporation SOC Ltd
Document type:
Invitation to bid
Project:
Smelter project
Compulsory site meeting date:
18 April 2024
Compulsory site meeting location:
Necsa Site, Pelindaba
Closing date:
10 May 2024
Closing time:
11:00
Bid validity period:
90 working days from closing date
Delivery address:
Necsa Gate 3, R104 Elias Motsoaledi Street, Pelindaba, Brits Magisterial District, Madibeng Municipality, North West, 0240
Applicable legislation:
Preferential Procurement Policy Framework Act and Preferential Procurement Regulations, 2022
Evaluation criteria:
Functionality, B-BBEE, and price using 80/20 and 90/10 preference point systems
Scope of work:
Design, manufacture, supply, delivery, installation, commissioning, and training related to one jaw crusher
Year:
2019
Region / City:
International
Theme:
Advanced Therapy Medicinal Products, Biological Medicinal Substances
Document Type:
Consultation Notice
Organization:
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Author:
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Target Audience:
Stakeholders in the pharmaceutical industry, academia, hospitals, and experts in biotechnology and manufacturing
Period of Validity:
20 September 2019 – 20 December 2019
Approval Date:
20 September 2019
Revision Date:
20 December 2019
Year:
2019
Region / City:
International
Topic:
Consultation on GMP for Advanced Therapy Medicinal Products and Biological Medicinal Substances
Document Type:
Consultation Notice
Organization / Institution:
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Author:
Pharmaceutical Inspection Co-operation Scheme (PIC/S)
Target Audience:
Academia, hospitals, pharmaceutical industry, subject matter experts
Period of validity:
September 20, 2019 - December 20, 2019
Approval Date:
September 20, 2019
Date of Changes:
None specified
Document type:
Quality Technical Agreement
Subject:
Manufacture, overlabelling, importation, release and distribution of investigational medicinal products
Applicable regulations:
GMP, GDP, Medicines for Human Use (Clinical Trials) Regulations 2004 (SI 2004/1031), ICH Good Clinical Practice, Declaration of Helsinki 1996
Parties:
Sponsor Organisation; Manufacturing Organisation; Importing Organisation
Geographic scope:
Great Britain
Intended use:
Clinical trials
Term:
Up to five years from final signature
Review frequency:
Every five years
Annexes:
Drug products and services; Responsibilities of each Party; Key Contact Persons; List of Subcontractors; Technical Agreement Approval; Version History
Providing organisation:
The Newcastle upon Tyne Hospitals NHS Foundation Trust Quality Assurance Pharmacy Team
Source type:
Contractual regulatory document governing quality responsibilities in clinical research supply chains
Year:
2026
Country:
Pakistan
Authority:
Drug Regulatory Authority of Pakistan
Document Type:
Application Form
Subject:
Registration and Renewal of Medical Devices
Applicable Classes:
B, C, D
Submission Requirements:
Enclosures, Certificates, Softcopy on USB/CD
Responsible Person:
Proprietor, Chief Executive, Managing Director or Authorized Officer
Legal Reference:
Drug Regulatory Authority of Pakistan Act, 2012
Intended Use:
Local Manufacture of Medical Devices
Note:
Year
Subject:
Drug registration for local manufacture
Document Type:
Application form
Organization / Institution:
Ministry of Health
Author:
Applicant
Target Audience:
Pharmaceutical manufacturers
Year:
2022
Region / City:
Florida
Topic:
Criminal law, controlled substances
Document type:
Legal instruction
Agency / Institution:
Florida State
Author:
Florida Legislature
Target audience:
Legal professionals, judges
Period of validity:
Ongoing
Approval date:
15 December 2021
Date of amendments:
21 December 2022